Synthesis and Anti-Inflammatory Activity of 2-{[5-(2-Chlorophenyl)-4H-1,2,4-Triazol- 3-YL]Sulfanyl}-1-(Substituted Phenyl)Ethanones
- Authors: Karande N.A.1, Rathi L.G.1
- 
							Affiliations: 
							- Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research
 
- Issue: Vol 51, No 7 (2017)
- Pages: 558-563
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244707
- DOI: https://doi.org/10.1007/s11094-017-1654-8
- ID: 244707
Cite item
Abstract
With the aim of obtaining potential anti-inflammatory compounds, 2-{[5-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-1-(phenyl)ethanone and a series of its derivatives were synthesized, purified by flash chromatography, and characterised by spectral and elemental analysis. All the new synthesized compounds were evaluated for their anti-inflammatory activity using carrageenan-induced paw edema test on Wistar albino rats. The results suggest that 1-(4-fluorophenyl)-2-{[5-(2-chlorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}ethanone 7l exhibit remarkable activity when compared with indomethacin even in the absence of carboxyl group in its structure, which reduces the possibility of gastric irritation.
About the authors
N. A. Karande
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research
							Author for correspondence.
							Email: n.k.0704@gmail.com
				                					                																			                												                	India, 							Wardha, Borgaon (Meghe), 442001						
L. G. Rathi
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research
														Email: n.k.0704@gmail.com
				                					                																			                												                	India, 							Wardha, Borgaon (Meghe), 442001						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					